CMA
61
5
WBA
48
4
FSLR
54
7
PEP
48
6
SE
61
-4
PYPL
54
2
R
71
4
INTU
56
-4
AON
54
2
ORLY
62
2
CHRW
56
-3
LYB
39
2
HCP
66
8
VFC
53
5
LNC
39
3
KEY
46
3
GT
62
6
ADBE
49
3
CAH
48
-5
COF
60
2
CMA
61
5
WBA
48
4
FSLR
54
7
PEP
48
6
SE
61
-4
PYPL
54
2
R
71
4
INTU
56
-4
AON
54
2
ORLY
62
2
CHRW
56
-3
LYB
39
2
HCP
66
8
VFC
53
5
LNC
39
3
KEY
46
3
GT
62
6
ADBE
49
3
CAH
48
-5
COF
60
2
Financhill
Back

Amicus Therapeutics Vs. Alnylam Pharmaceuticals Industry Stock Comparison

Sell
29

FOLD
Amicus Therapeutics

Last Price:
9.68
Seasonality Move:
7.75%
Sell
23

ALNY
Alnylam Pharmaceuticals

Last Price:
244.97
Seasonality Move:
11.66%
Sell
29
Amicus Therapeutics (FOLD) is a Sell

Is Amicus Therapeutics a Buy, Sell or Hold?

  • The current Amicus Therapeutics [FOLD] share price is $9.66. The Score for FOLD is 29, which is 42% below its historic median score of 50, and infers higher risk than normal.
  • FOLD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Alnylam Pharmaceuticals (ALNY) is a Sell

Is Alnylam Pharmaceuticals a Buy, Sell or Hold?

  • The current Alnylam Pharmaceuticals [ALNY] share price is $244.89. The Score for ALNY is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

FOLD Stock Price Chart

What is Amicus Therapeutics's stock price today?

  • The Amicus Therapeutics share price today is $9.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FOLD is experiencing slight buying pressure.

ALNY Stock Price Chart

What is Alnylam Pharmaceuticals's stock price today?

  • The Alnylam Pharmaceuticals share price today is $244.89
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ALNY is experiencing slight selling pressure.

FOLD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.43 Sell
Relative Strength Index (14 RSI): 32.67 Sell
Chaikin Money Flow: 481094 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (10.02 - 11.72) Sell
Bollinger Bands (100): (10.17 - 11.55) Sell

ALNY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -9.65 Sell
Relative Strength Index (14 RSI): 37.82 Sell
Chaikin Money Flow: -229766 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (250.02 - 288.16) Sell
Bollinger Bands (100): (248.72 - 281.72) Sell

FOLD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 9.76 Sell
20-day SMA: 10.65 Sell
50-day SMA: 10.81 Sell
200-day SMA: 10.98 Sell
8-day EMA: 9.84 Sell
20-day EMA: 10.35 Sell
50-day EMA: 10.71 Sell
200-day EMA: 11.01 Sell

ALNY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 245.62 Sell
20-day SMA: 263.27 Sell
50-day SMA: 272.49 Sell
200-day SMA: 211.63 Buy
8-day EMA: 248.36 Sell
20-day EMA: 259.36 Sell
50-day EMA: 265.3 Sell
200-day EMA: 231.03 Buy

Amicus Therapeutics Earnings Growth & FOLD Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.21 per share.

Alnylam Pharmaceuticals Earnings Growth & ALNY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.46 per share, and an increase next year of $0.61 per share.

Amicus Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Alnylam Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):